Consultation on role of incentive schemes in general practice

The Government is consulting on the role and value of incentive schemes like the Quality and Outcomes Framework (QOF) and the Impact and Investment Fund (IIF) in shaping and driving improvements in the delivery of general practice services.

In order to inform Londonwide LMCs' response to the consultation, and the advice we share with London practices, we would welcome your thoughts on the questions posed in the Government consultation by Friday 16 February.
Please feel to answer as many or as few questions as you wish.

Question Title

* 1. Do you agree or disagree that incentives like QOF and IIF should form part of the income for general practice?

Question Title

* 2. Please expand on your previous answer (whether you agree or disagree that incentives like QOF and IIF should form part of the income for general practice).

Question Title

* 3. Do you agree or disagree that QOF and IIF help ensure that sufficient resources are applied to preventative and proactive care?

Question Title

* 4. Please expand on your previous answer (whether you agree or disagree that QOF and IIF help ensure that sufficient resources are applied to preventative and proactive care).

Question Title

* 5. Would relative improvement targets be more effective than absolute targets at delivering improvements in care quality while also addressing health inequalities?

Question Title

* 6. Please expand on your previous answer (re whether relative improvement targets would be more effective than absolute targets at delivering improvements in care quality while also addressing health inequalities).

Question Title

* 7. To what degree, if any, do you think that ICBs should influence the nature of any incentive scheme?

Question Title

* 8. Please expand on your previous answer (re whether ICBs should influence the nature of any incentive scheme).

Question Title

* 9. Do you agree or disagree that a PCN-level incentive scheme like IIF encourages PCN-wide efforts to improve quality?

Question Title

* 10. Please expand on your previous answer (re whether a PCN-level incentive scheme like IIF encourages PCN-wide efforts to improve quality).

Question Title

* 11. What type of indicators, if any, within incentive schemes do you think most help to improve care quality? (Select all that apply)

Question Title

* 12. If you said ‘other’, please describe the nature of the indicators you think would be effective in improving care.

Question Title

* 13. Do you think there is a role for incentives to reward practices for clinical outcomes measured at PCN or place level?

Question Title

* 14. Please expand on your previous answer (describe how you think we could best focus on clinical outcomes).

Question Title

* 15. Do you agree or disagree that there is a role for incentive schemes to focus on helping to reduce pressures on other parts of the health system?

Question Title

* 16. Please expand on your previous answer.

Question Title

* 17. Do you agree or disagree that incentives should be more tailored towards quality of care for patients with multiple long-term conditions?

Question Title

* 18. Please expand on your previous answer. How could an incentive scheme be tailored more towards quality of care for patients with multiple long-term conditions? Or could it not be?

Question Title

* 19. Do you agree or disagree that patient experience of access could be improved if included in an incentive scheme?

Question Title

* 20. Please expand on your previous answer. If you said ‘agree’, how could patient access be incentivised and measured? If you said ‘disagree’, please explain your answer.

Question Title

* 21. Do you agree or disagree that continuity of care could be improved if included in an incentive scheme?

Question Title

* 22. Please expand on your previous answer. If you said ‘agree’, how could continuity be measured and incentivised? If you said ‘disagree’, please explain your answer.

Question Title

* 23. Do you agree or disagree that patient choice could be improved if included in an incentive scheme?

Question Title

* 24. If you said ‘agree’, how could we incentivise and measure patient choice in any incentive schemes? If you said ‘disagree’, please explain your answer.

Question Title

* 25. Do you agree or disagree that the effectiveness of prescribing could be improved if included in an incentive scheme?

Question Title

* 26. If you said ‘agree’, how could we incentivise effective prescribing in any incentive schemes? If you said ‘disagree’, please explain your answer.

Question Title

* 27. Are there any other areas that should be considered for inclusion within an incentive scheme? Please explain your answer.

Question Title

* 28. What opportunities are there to simplify and streamline any schemes for clinicians, and reduce any unnecessary administrative burden, while preserving patient care? Please explain your answer.

Question Title

* 29. What is your LMC (this helps us gauge whether there are different issues arising in different geographies)?

Question Title

* 30. If you would like to receive a copy of the response submitted to the Government consultation and/ or be contacted for further information on your answers, please provide your contact details.

T